Panacea Biotec Ltd

In continuation to our letter dated February 14 2023 we would like to inform you that we have noted that due to inadvertent typographical/clerical error the consolidated figures for Depreciation and amortisation expenses and Finance costs for the nine months ended December 31 2022 as mentioned in the Statement of Standalone and Consolidated Financial Results (Unaudited) for the quarter and nine months ended December 31 2022 were replaced with each other as a result of which the consolidated figures for these items for the quarter and nine months ended December 31 2022 got mentioned incorrect.